M
Magnus Løberg
Researcher at Oslo University Hospital
Publications - 98
Citations - 3149
Magnus Løberg is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Medicine & Colonoscopy. The author has an hindex of 19, co-authored 73 publications receiving 2237 citations. Previous affiliations of Magnus Løberg include Massachusetts Institute of Technology & University of Oslo.
Papers
More filters
Journal ArticleDOI
Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Cesare Hassan,Enrique Quintero,Jean-Marc Dumonceau,Jaroslaw Regula,Catarina Brandão,Stanislas Chaussade,Evelien Dekker,Mário Dinis-Ribeiro,Monika Ferlitsch,Antonio Z. Gimeno-García,Yark Hazewinkel,Rodrigo Jover,Mette Kalager,Magnus Løberg,Magnus Løberg,Christian Pox,B. Rembacken,David A. Lieberman +17 more
TL;DR: The following recommendations for post-polypectomy endoscopic surveillance should be applied only after a high quality baseline colonoscopy with complete removal of all detected neoplastic lesions.
Journal ArticleDOI
Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality A Randomized Clinical Trial
Øyvind Holme,Magnus Løberg,Mette Kalager,Michael Bretthauer,Miguel A. Hernán,Miguel A. Hernán,Eline Aas,Tor J. Eide,Eva Skovlund,Jörn Schneede,Kjell Magne Tveit,Geir Hoff +11 more
TL;DR: In Norway, once-only flexible sigmoidoscopy screening or flexible sigmatoscopy and FOBT reduced colorectal cancer incidence and mortality on a population level compared with no screening.
Journal ArticleDOI
Benefits and harms of mammography screening
Magnus Løberg,Magnus Løberg,Magnus Løberg,Mette Lise Lousdal,Michael Bretthauer,Mette Kalager,Mette Kalager +6 more
TL;DR: The benefits and harms of mammography screening in light of findings from randomized trials and from more recent observational studies performed in the era of modern diagnostics and treatment are discussed.
Journal ArticleDOI
Long-Term Colorectal-Cancer Mortality after Adenoma Removal
Magnus Løberg,Mette Kalager,Øyvind Holme,Geir Hoff,Hans-Olov Adami,Hans-Olov Adami,Hans-Olov Adami,Michael Bretthauer +7 more
TL;DR: After a median of 7.7 years of follow-up, colorectal-cancer mortality was lower among patients who had had low- risk adenomas removed and moderately higher among those who hadHad high-risk adenoma removed, as compared with the general population.
Journal ArticleDOI
Population-Based colonoscopy screening for colorectal cancer : A randomized clinical trial
Michael Bretthauer,Michael Bretthauer,Michael Bretthauer,Michal F. Kaminski,Magnus Løberg,Magnus Løberg,Ann G. Zauber,Jaroslaw Regula,Ernst J. Kuipers,Miguel A. Hernán,Miguel A. Hernán,Eleanor McFadden,Annike Sunde,Mette Kalager,Mette Kalager,Mette Kalager,Evelien Dekker,Iris Lansdorp-Vogelaar,Kjetil Garborg,Maciej Rupinski,Manon C.W. Spaander,Marek Bugajski,Ole Høie,Tryggvi Stefansson,Geir Hoff,Hans-Olov Adami +25 more
TL;DR: A population-based randomized clinical trial was conducted among 94 959 men and women aged 55 to 64 years of average risk for colon cancer in Poland, Norway, the Netherlands, and Sweden to investigate participation rate, adenoma yield, performance, and adverse events of population- based colonoscopy screening in several European countries.